The FDA has given psilocybin therapy for treatment-resistant depression a Breakthrough Therapy status. This classification suggests the treatment has demonstrated significant potential in early clinical evidence, allowing the FDA to assist and expedite subsequent development and review processes.
Watching
Latest
-
Access Denied
-
Experiments to dim the SUN in bid to curb global warming will be approved by the UK government within weeks | Daily Mail Online
-
Taiwan charges captain of Chinese ship Hong Tai 58 with damaging deep-sea cables | CNN
-
Ursula von der Leyen:. "Europe has the values of the Talmud" - Pravda FR